379 related articles for article (PubMed ID: 7237446)
1. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
[TBL] [Abstract][Full Text] [Related]
2. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
Sava G; Giraldi T; Lassiani L; Nisi C
Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
[TBL] [Abstract][Full Text] [Related]
3. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
Sava G; Giraldi T; Zupi G; Sacchi A
Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
[TBL] [Abstract][Full Text] [Related]
4. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Mitri E; Cherubino R
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195
[TBL] [Abstract][Full Text] [Related]
5. Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice.
Giraldi T; Houghton PJ; Taylor DM; Nisi C
Cancer Treat Rep; 1978 May; 62(5):721-5. PubMed ID: 657157
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
Sava G; Giraldi T; Nisi C; Bertoli G
Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247
[TBL] [Abstract][Full Text] [Related]
7. Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor lines with different metastatic capacity.
Zupi G; Corsi A; Sacchi A; Lassiani L; Giraldi T
Invasion Metastasis; 1984; 4(3):179-88. PubMed ID: 6480290
[TBL] [Abstract][Full Text] [Related]
8. Activity of 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt in M 5076/73A ovarian reticular cell sarcoma of the mouse.
Colombo T; Garattini S; Lassiani L; D'Incalci M
Cancer Treat Rep; 1982 Nov; 66(11):1945-8. PubMed ID: 6754075
[TBL] [Abstract][Full Text] [Related]
9. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
Sava G; Zorzet S; Perissin L; Lassiani L; Tomasic J
Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):477-80. PubMed ID: 4079598
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E
Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
Sava G; Zorzet S; Perissin L; Pacor S; Lassiani L; Nisi C; Varnavas A
Cancer Chemother Pharmacol; 1991; 27(6):423-8. PubMed ID: 2013112
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
13. Effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma.
James SE; Salsbury AJ
Cancer Res; 1974 Apr; 34(4):839-42. PubMed ID: 4814996
[No Abstract] [Full Text] [Related]
14. The effects of an antimetastatic agent, (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane (ICRF 159), on platelet behavior.
Atherton A; Busfield D; Hellman K
Cancer Res; 1975 Apr; 35(4):953-7. PubMed ID: 1116152
[TBL] [Abstract][Full Text] [Related]
15. Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.
Salsbury AJ; Burrage K; Hellmann K
Cancer Res; 1974 Apr; 34(4):843-9. PubMed ID: 4814997
[No Abstract] [Full Text] [Related]
16. Kinetic investigation of the aqueous stability and antitumor activity of a hydrosoluble diaryltriazene, AVIS, related to the antimetastatic agent DM-COOK.
Lassiani L; Ebert C; Nisi C; Varnavas A; Zorzet S; Sava G; Boccù E
Pharmazie; 1990 Oct; 45(10):743-5. PubMed ID: 2089382
[TBL] [Abstract][Full Text] [Related]
17. Activity and inhibition by cytotoxic and antimetastatic drugs of cathepsin B-like cysteine proteinase in transplantable leukemias in mice.
Giraldi T; Sava G; Zorzet S; Perissin L; Piccini P
Anticancer Res; 1987; 7(3 Pt B):343-6. PubMed ID: 3307599
[TBL] [Abstract][Full Text] [Related]
18. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cell-surface neutral protease of Ehrlich ascites tumor cells by potassium p-(3,3-dimethyl-1-triazeno) benzoate.
Steven FS; Brown BS; Hulley TP; Itzhaki S; Giraldi T; Lassiani L
Biochem Int; 1985 Aug; 11(2):153-60. PubMed ID: 3902023
[TBL] [Abstract][Full Text] [Related]
20. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
